Evidence map›Paper›PMID 26726318›Full record

ArticleTrends in cancer2015

Deciphering the Code of the Cancer Genome: Mechanisms of Chromosome Rearrangement.

Nicholas A Willis, Emilie Rass, Ralph Scully

Abstract read
In one paragraph

Article in Trends in cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Chromothripsis.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  6. Chromoanasynthesis.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Break-induced replication: unraveling each step.Trends in genetics : TIG · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Building genomes to understand biology.Nature communications · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicholas A WillisDepartment of Medicine, Division of Hematology Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215.
Emilie RassDepartment of Medicine, Division of Hematology Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215.
Ralph ScullyDepartment of Medicine, Division of Hematology Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215.

Funding

ANALYSIS OF BRCA1 RECOMBINATION FUNCTIONSR01CA095175 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2002 to 2021
$4.9M
The chromatin response in mammalian double strand break repairR01GM073894 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2005 to 2014
$2.5M
A mouse model for studying homologous recombination fidelity during agingR21AG042848 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2015 to 2016
$479k
NCI NIH HHS R01 CA095175NIA NIH HHS R21 AG042848NIGMS NIH HHS R01 GM073894
6 · The paper itself

Abstract

Chromosome rearrangement plays a causal role in tumorigenesis by contributing to the inactivation of tumor suppressor genes, the dysregulated expression or amplification of oncogenes and the generation of novel gene fusions. Chromosome breaks are important intermediates in this process. How, when and where these breaks arise and the specific mechanisms engaged in their repair strongly influence the resulting patterns of chromosome rearrangement. Here, we review recent progress in understanding how certain distinctive features of the cancer genome, including clustered mutagenesis, tandem segmental duplications, complex breakpoints, chromothripsis, chromoplexy and chromoanasynthesis may arise.

Identifiers

PMID26726318
PMCPMC4695301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.